🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Perihilar Cholangiocarcinoma

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma NCT06175845NA9 sites📍 Berlin📍 Bonn📍 Chemnitz Universitätsklinikum Hamburg-Eppendorf · Tests: Intraductal biliary radiofrequency ablation Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study NCT06964425NA1 site📍 Olomouc University Hospital Olomouc · Tests: Endoscopic retrograde cholangiopancreatography (ERCP) Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and Intrahepatic Cholangiocarcinoma NCT06440993Phase 212 sites📍 Aachen📍 Bonn📍 Cologne Institut für Klinische Krebsforschung IKF GmbH at Krankenha… · Tests: Gemcitabine, Cisplatin, Durvalumab, ID-RFA Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study. NCT04378023n/a1 site📍 Barcelona Hospital Vall d'Hebron · Tests: Neoadjuvant Chemo-radiotherapy, Liver Transplantation Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma NCT07030140Phase 21 site📍 Jinan Jinbo Yue · Tests: Stereotactic Body Radiotherapy (SBRT), Tislelizumab, Gemcitabine, Cisplatin or Oxaliplatin Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy NCT05551299Phase 420 sites📍 Aachen📍 Augsburg📍 Berlin University of Leipzig · Tests: Photosensitizer, Radiofrequency ablation (RFA) Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma NCT05546372NA1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Endobiliary radiofrequency ablation (eRFA), uncovered self-expanding metal stent (uSEMS) A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening NCT07176962n/a1 site📍 Shanghai Yingbin Liu, MD, PhD, FACS LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) NCT06125769NA1 site📍 Padova Azienda Sanitaria Ospedaliera · Tests: Liver transplantation En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria NCT06850753NA1 site📍 Oslo Oslo University Hospital · Tests: Liver transplantation after en bloc resection of the liver and pancreas Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma NCT04993131NA1 site📍 Oslo Oslo University Hospital · Tests: Liver transplant HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocarcinoma NCT07795619NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: IRE+chemotherapy, chemotherapy DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection. NCT07717437n/a31 sites📍 Chicago📍 Rochester📍 Cleveland Maastricht University Medical Center PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma NCT05430698Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: PD-1antibody plus GEMOX Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study NCT06720883n/a1 site📍 Padova Azienda Ospedaliera di Padova · Tests: Major hepatectomy Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma NCT06923475Phase 2, Phase 31 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Pembrolizumab, Gemcitabine, Cisplatin Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma NCT06493734NA8 sites📍 Wilrijk📍 Brussels📍 Nijmegen Erasmus Medical Center · Tests: Stereotactic body radiation therapy Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) NCT07161869n/a6 sites📍 Rotterdam📍 Amsterdam📍 Groningen Erasmus Medical Center · Tests: Registration of all findings during preoperative Endoscopic Ultrasound Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma NCT06986486n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy